作为α-淀粉酶和α-葡萄糖苷酶双重抑制剂的噻唑烷-2,4-二酮杂交化合物:设计、合成、体外和体内抗糖尿病评价

IF 4.1 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Gurpreet Singh, Rajveer Singh, Vikramdeep Monga and Sidharth Mehan
{"title":"作为α-淀粉酶和α-葡萄糖苷酶双重抑制剂的噻唑烷-2,4-二酮杂交化合物:设计、合成、体外和体内抗糖尿病评价","authors":"Gurpreet Singh, Rajveer Singh, Vikramdeep Monga and Sidharth Mehan","doi":"10.1039/D4MD00199K","DOIUrl":null,"url":null,"abstract":"<p >Twelve 3,5-disubstituted-thiazolidine-2,4-dione (TZD) hybrids were synthesized using solution phase chemistry. Continuing our previous work, nine <em>O</em>-modified ethyl vanillin (<strong>8a–i</strong>) derivatives were synthesized and reacted with the TZD core <em>via</em> Knoevenagel condensation under primary reaction conditions to obtain final derivatives <strong>9a–i</strong>. Additionally, three isatin–TZD hybrids (<strong>11a–c</strong>) were synthesized. The intermediates and final derivatives were characterized using <small><sup>1</sup></small>H and <small><sup>13</sup></small>C NMR spectroscopy, and the observed chemical shifts agreed with the proposed structures. The <em>in vitro</em> alpha-amylase and alpha-glucosidase inhibitory evaluation of newly synthesized derivatives revealed compounds <strong>9F</strong> and <strong>9G</strong> as the best dual inhibitors, with IC<small><sub>50</sub></small> values of 9.8 ± 0.047 μM for alpha-glucosidase (<strong>9F</strong>) and 5.15 ± 0.0017 μM for alpha-glucosidase (<strong>9G</strong>), 17.10 ± 0.015 μM for alpha-amylase (<strong>9F</strong>), and 9.2 ± 0.092 μM for alpha-amylase (<strong>9G</strong>). The docking analysis of synthesized compounds indicated that compounds have a higher binding affinity for alpha-glucosidase as compared to alpha-amylase, as seen from docking scores ranging from −1.202 to −5.467 (for alpha-amylase) and −4.373 to −7.300 (for alpha-glucosidase). Further, the molecules possess a high LD<small><sub>50</sub></small> value, typically ranging from 1000 to 1600 mg kg<small><sup>−1</sup></small> of body weight, and exhibit non-toxic properties. The <em>in vitro</em> cytotoxicity assay results on PANC-1 and INS-1 cells demonstrated that the compounds were devoid of significant toxicity against the tested cells. Compounds <strong>9F</strong> and <strong>9G</strong> showed high oral absorption, <em>i.e.</em>, oral absorption &gt;96%, and their molecular dynamics simulation yielded results closely aligned with the observed docking outcomes. Finally, compounds <strong>9F</strong> and <strong>9G</strong> were evaluated for <em>in vivo</em> antidiabetic assessment by the induction of diabetes in Wistar rats using streptozotocin. Molecule <strong>9G</strong> has been identified as the most effective anti-diabetic molecule due to its ability to modulate several biochemical markers in blood plasma and tissue homogenates. The results were further confirmed by histology investigations conducted on isolated pancreas, liver, and kidney.</p>","PeriodicalId":21462,"journal":{"name":"RSC medicinal chemistry","volume":" 8","pages":" 2826-2854"},"PeriodicalIF":4.1000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation†\",\"authors\":\"Gurpreet Singh, Rajveer Singh, Vikramdeep Monga and Sidharth Mehan\",\"doi\":\"10.1039/D4MD00199K\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Twelve 3,5-disubstituted-thiazolidine-2,4-dione (TZD) hybrids were synthesized using solution phase chemistry. Continuing our previous work, nine <em>O</em>-modified ethyl vanillin (<strong>8a–i</strong>) derivatives were synthesized and reacted with the TZD core <em>via</em> Knoevenagel condensation under primary reaction conditions to obtain final derivatives <strong>9a–i</strong>. Additionally, three isatin–TZD hybrids (<strong>11a–c</strong>) were synthesized. The intermediates and final derivatives were characterized using <small><sup>1</sup></small>H and <small><sup>13</sup></small>C NMR spectroscopy, and the observed chemical shifts agreed with the proposed structures. The <em>in vitro</em> alpha-amylase and alpha-glucosidase inhibitory evaluation of newly synthesized derivatives revealed compounds <strong>9F</strong> and <strong>9G</strong> as the best dual inhibitors, with IC<small><sub>50</sub></small> values of 9.8 ± 0.047 μM for alpha-glucosidase (<strong>9F</strong>) and 5.15 ± 0.0017 μM for alpha-glucosidase (<strong>9G</strong>), 17.10 ± 0.015 μM for alpha-amylase (<strong>9F</strong>), and 9.2 ± 0.092 μM for alpha-amylase (<strong>9G</strong>). The docking analysis of synthesized compounds indicated that compounds have a higher binding affinity for alpha-glucosidase as compared to alpha-amylase, as seen from docking scores ranging from −1.202 to −5.467 (for alpha-amylase) and −4.373 to −7.300 (for alpha-glucosidase). Further, the molecules possess a high LD<small><sub>50</sub></small> value, typically ranging from 1000 to 1600 mg kg<small><sup>−1</sup></small> of body weight, and exhibit non-toxic properties. The <em>in vitro</em> cytotoxicity assay results on PANC-1 and INS-1 cells demonstrated that the compounds were devoid of significant toxicity against the tested cells. Compounds <strong>9F</strong> and <strong>9G</strong> showed high oral absorption, <em>i.e.</em>, oral absorption &gt;96%, and their molecular dynamics simulation yielded results closely aligned with the observed docking outcomes. Finally, compounds <strong>9F</strong> and <strong>9G</strong> were evaluated for <em>in vivo</em> antidiabetic assessment by the induction of diabetes in Wistar rats using streptozotocin. Molecule <strong>9G</strong> has been identified as the most effective anti-diabetic molecule due to its ability to modulate several biochemical markers in blood plasma and tissue homogenates. The results were further confirmed by histology investigations conducted on isolated pancreas, liver, and kidney.</p>\",\"PeriodicalId\":21462,\"journal\":{\"name\":\"RSC medicinal chemistry\",\"volume\":\" 8\",\"pages\":\" 2826-2854\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"RSC medicinal chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00199k\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00199k","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

我们利用溶液相化学合成了十二种 3,5-二取代噻唑烷-2,4-二酮(TZD)杂交化合物。延续我们之前的工作,合成了九种 O-修饰乙基香兰素(8a-i)衍生物,并在一级反应条件下通过克诺文纳格尔缩合与 TZD 核心反应,得到最终衍生物 9a-i。此外,还合成了三种异汀-TZD 杂化物(11a-c)。利用 1H 和 13C NMR 光谱对中间体和最终衍生物进行了表征,观察到的化学位移与所提出的结构一致。对新合成衍生物进行的体外α-淀粉酶和α-葡萄糖苷酶抑制性评价显示,化合物 9F 和 9G 是最佳的双重抑制剂,其 IC50 值为 9.对α-葡萄糖苷酶(9F)的 IC50 值为 9.8 ± 0.047 μM,对α-葡萄糖苷酶(9G)的 IC50 值为 5.15 ± 0.0017 μM;对α-淀粉酶(9F)的 IC50 值为 17.10 ± 0.015 μM,对α-淀粉酶(9G)的 IC50 值为 9.2 ± 0.092 μM。对合成的化合物进行的对接分析表明,与α-淀粉酶相比,化合物与α-葡萄糖苷酶的结合亲和力更高,对接得分从-1.202 到-5.467(α-淀粉酶)和-4.373 到-7.300(α-葡萄糖苷酶)不等。此外,这些分子还具有较高的半数致死剂量(LD50),通常为 1000 至 1600 毫克/千克体重,并表现出无毒特性。对 PANC-1 和 INS-1 细胞进行的体外细胞毒性试验结果表明,这些化合物对受试细胞无明显毒性。化合物 9F 和 9G 显示出较高的口服吸收率,即口服吸收率为 96%,其分子动力学模拟结果与观察到的对接结果非常吻合。最后,通过使用链脲佐菌素诱导 Wistar 大鼠患糖尿病,对化合物 9F 和 9G 进行了体内抗糖尿病评估。由于分子 9G 能够调节血浆和组织匀浆中的多种生化指标,因此被确定为最有效的抗糖尿病分子。对离体胰腺、肝脏和肾脏进行的组织学研究进一步证实了这一结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation†

Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation†

Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation†

Twelve 3,5-disubstituted-thiazolidine-2,4-dione (TZD) hybrids were synthesized using solution phase chemistry. Continuing our previous work, nine O-modified ethyl vanillin (8a–i) derivatives were synthesized and reacted with the TZD core via Knoevenagel condensation under primary reaction conditions to obtain final derivatives 9a–i. Additionally, three isatin–TZD hybrids (11a–c) were synthesized. The intermediates and final derivatives were characterized using 1H and 13C NMR spectroscopy, and the observed chemical shifts agreed with the proposed structures. The in vitro alpha-amylase and alpha-glucosidase inhibitory evaluation of newly synthesized derivatives revealed compounds 9F and 9G as the best dual inhibitors, with IC50 values of 9.8 ± 0.047 μM for alpha-glucosidase (9F) and 5.15 ± 0.0017 μM for alpha-glucosidase (9G), 17.10 ± 0.015 μM for alpha-amylase (9F), and 9.2 ± 0.092 μM for alpha-amylase (9G). The docking analysis of synthesized compounds indicated that compounds have a higher binding affinity for alpha-glucosidase as compared to alpha-amylase, as seen from docking scores ranging from −1.202 to −5.467 (for alpha-amylase) and −4.373 to −7.300 (for alpha-glucosidase). Further, the molecules possess a high LD50 value, typically ranging from 1000 to 1600 mg kg−1 of body weight, and exhibit non-toxic properties. The in vitro cytotoxicity assay results on PANC-1 and INS-1 cells demonstrated that the compounds were devoid of significant toxicity against the tested cells. Compounds 9F and 9G showed high oral absorption, i.e., oral absorption >96%, and their molecular dynamics simulation yielded results closely aligned with the observed docking outcomes. Finally, compounds 9F and 9G were evaluated for in vivo antidiabetic assessment by the induction of diabetes in Wistar rats using streptozotocin. Molecule 9G has been identified as the most effective anti-diabetic molecule due to its ability to modulate several biochemical markers in blood plasma and tissue homogenates. The results were further confirmed by histology investigations conducted on isolated pancreas, liver, and kidney.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.80
自引率
2.40%
发文量
129
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信